Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ChemPartner Expands China Ops | Contract Pharma
Breaking News

ChemPartner Expands China Ops

Introduces new state-of-the-art global operation center in Shanghai

Shanghai ChemPartner has opened a new, state-of-the-art, 24,000 square meter laboratory facility in the Zhangjiang Hi-Tech Park in Shanghai, China.
 
The building, operating as ChemPartner’s new Global Operation Center, houses approximately 700 employees and new laboratories for ChemPartner’s discovery chemistry, biology and pharmacology, and the DMPK and exploratory toxicology departments. It also has a nearly 2,000 square meter, AAALAC accredited animal facility.
 
“This facility demonstrates ChemPartner’s commitment to be an innovative, technology-driven CRO,” said Michael Hui, chairman, ChemPartner. “We invested $35 million dollars into this new facility to make it a premiere drug discovery and development solution for our global clients.”
 
Dr. Wei Tang, president, ChemPartner, said, “All of us at ChemPartner are dedicated to research innovation to provide our biopharmaceutical clients with exceptional quality and timely results. Along with our Innovation Center in San Francisco, California, this new facility in Shanghai shows our dedication to technically and strategically accomplishing the research initiatives of our clients.”
 
In addition to laboratory and scientific teams, the new Global Operations Center also houses ChemPartner’s administration, finance, and legal teams.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters